AQR Capital Management »

Newamsterdam Pharma Co Nv shares owned by AQR Capital Management

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $265k 16k 16.60

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ge Aerospace Com New (GE)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Zoom Video Communications In Cl A (ZM)
Cigna Corp (CI)
At&t (T)
Progressive Corporation (PGR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for AQR Capital Management

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
RA Capital Management
Viking Global Investors
Medicxi Ventures Management
BVF
Woodline Partners
Jennison Associates
Pictet Asset Management Holding SA
Siren
Deerfield Management Company
Avidity Partners Management
Decheng Capital
Citadel Advisors
Affinity Asset Advisors
Arrowpoint Asset Management

View all funds holding Newamsterdam Pharma Co Nv